Asymptomatic Aortic Stenosis: A Complex Decision

Asymptomatic severe aortic stenosis continues to pose a significant challenge when it comes to clinical decision-making, often due to the difficulty in identifying symptoms. When this condition is symptomatic or oligosymptomatic, it is associated with increased rates of hospitalization and mortality.

While current guidelines recommend valve replacement in cases of impaired ventricular function, available reports are not definitive regarding its implementation.

Researchers conducted a meta-analysis that included four randomized studies (EARLY TAVR, EVoLVeD, AVATAR, and RECOVERY), with a total of 1427 patients. Of these, 719 underwent early aortic valve replacement through surgical or transcatheter aortic valve replacement (SAVR or TAVR), while the rest underwent clinical follow-up (CF) alone.

Read also: 1-Year Outcomes of US TAVR Registry with 5th Generation Balloon Expandable Valves.

With an average follow-up of four years, TAVR demonstrated a significant reduction in the rates of hospitalization due to cardiovascular causes or heart failure (combined rate: 14.6% vs. 31.9%; hazard ratio [HR]: 0.40; 95% confidence interval [CI]: 0.30–0.53; I² = 4%; p < 0.01) and in the incidence of stroke (combined rate: 4.5% vs. 7.2%; HR: 0.62; 95% CI: 0.40–0.97; I² = 0%; p = 0.03). However, there were no significant differences in all-cause mortality (combined rate: 9.7% vs. 13.7%; HR: 0.68; 95% CI: 0.40–1.17; I² = 61%; p = 0.17) or cardiovascular mortality (combined rate: 5.1% vs. 8.3%; HR: 0.67; 95% CI: 0.35–1.29; I² = 50%; p = 0.23). It is worth noting that the studies analyzed were highly heterogeneous.

Conclusion

In this meta-analysis of four randomized studies, early aortic valve replacement was associated with a significant reduction in hospitalization rates due to cardiovascular causes or heart failure, as well as in the incidence of stroke. However, there were no differences in all-cause mortality or cardiovascular mortality compared to clinical follow-up.

Original Title: Aortic Valve Replacement vs Clinical Surveillance in Asymptomatic Severe Aortic Stenosis: A Systematic Review and Meta-Analysis. 

Reference: Philippe Généreux, et al. JACC article in press.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

Dr. Carlos Fava
Dr. Carlos Fava
Member of the Editorial Board of solaci.org

More articles by this author

TAVI and Aortic Regurgitation: Are All Valves the Same?

Aortic regurgitation (AR) accounts for 0.5- 2.2% of all cases of valve disease in individuals over 65 years old. According to current guidelines, surgery is...

1-Year Outcomes of US TAVR Registry with 5th Generation Balloon Expandable Valves

The use of transcatheter aortic valve replacement (TAVR) has extended to younger patients with lower risk severe aortic stenosis (AS) and therefore the improvement...

EuroSMR Registry: Edge-to-Edge Mitral Treatment with 5-Year Outcomes

Cardiomyopathies and left atrial enlargement can lead to secondary mitral regurgitation (SMR). This condition is associated with ventricular dysfunction, causing heart failure, hospitalization, and...

TricValve Transcatheter Bicaval Valve System for Severe Tricuspid Insufficiency: Events at One Year

TricValve is the first bicaval valve system to obtain CE-Mark approval. This device heterotopic device eliminates tricuspid insufficiency reflux into the venous system, reducing...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ROUTE TRAIL: DKCRUSH vs. DKRUSH Culotte in Non-Left Main Bifurcation Lesions

Coronary bifurcation lesions represent a frequent technical challenge, making between 15% and 20% of cases. Though provisional stenting is mostly used, complex bifurcations are...

TENDERA: Comparing Conventional vs. Distal Transradial Occlusion for Coronary Interventions

Supported by robust data, favorably compared against the transfemoral, the transradial approach has consolidated as the safest method for percutaneous intervention, particularly in terms...

TAVI and Aortic Regurgitation: Are All Valves the Same?

Aortic regurgitation (AR) accounts for 0.5- 2.2% of all cases of valve disease in individuals over 65 years old. According to current guidelines, surgery is...